Literature DB >> 18438844

Expression of microRNA-146 in rheumatoid arthritis synovial tissue.

Tomoyuki Nakasa1, Shigeru Miyaki, Atsuko Okubo, Megumi Hashimoto, Keiichiro Nishida, Mitsuo Ochi, Hiroshi Asahara.   

Abstract

OBJECTIVE: Several microRNA, which are approximately 22-nucleotide noncoding RNAs, exhibit tissue-specific or developmental stage-specific expression patterns and are associated with human diseases. The objective of this study was to identify the expression pattern of microRNA-146 (miR-146) in synovial tissue from patients with rheumatoid arthritis (RA).
METHODS: The expression of miR-146 in synovial tissue from 5 patients with RA, 5 patients with osteoarthritis (OA), and 1 normal subject was analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR) and by in situ hybridization and immunohistochemistry of tissue sections. Induction of miR-146 following stimulation with tumor necrosis factor alpha (TNFalpha) and interleukin-1beta (IL-1beta) of cultures of human rheumatoid arthritis synovial fibroblasts (RASFs) was examined by quantitative PCR and RT-PCR.
RESULTS: Mature miR-146a and primary miR-146a/b were highly expressed in RA synovial tissue, which also expressed TNFalpha, but the 2 microRNA were less highly expressed in OA and normal synovial tissue. In situ hybridization showed primary miR-146a expression in cells of the superficial and sublining layers in synovial tissue from RA patients. Cells positive for miR-146a were primarily CD68+ macrophages, but included several CD3+ T cell subsets and CD79a+ B cells. Expression of miR-146a/b was markedly up-regulated in RASFs after stimulation with TNFalpha and IL-1beta.
CONCLUSION: This study shows that miR-146 is expressed in RA synovial tissue and that its expression is induced by stimulation with TNFalpha and IL-1beta. Further studies are required to elucidate the function of miR-146 in these tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438844      PMCID: PMC2749927          DOI: 10.1002/art.23429

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

1.  The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.

Authors:  Kyle Kai-How Farh; Andrew Grimson; Calvin Jan; Benjamin P Lewis; Wendy K Johnston; Lee P Lim; Christopher B Burge; David P Bartel
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

2.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

3.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.

Authors:  Thimmaiah P Chendrimada; Richard I Gregory; Easwari Kumaraswamy; Jessica Norman; Neil Cooch; Kazuko Nishikura; Ramin Shiekhattar
Journal:  Nature       Date:  2005-06-22       Impact factor: 49.962

4.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

5.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

6.  A cellular microRNA mediates antiviral defense in human cells.

Authors:  Charles-Henri Lecellier; Patrice Dunoyer; Khalil Arar; Jacqueline Lehmann-Che; Stephanie Eyquem; Christophe Himber; Ali Saïb; Olivier Voinnet
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

7.  The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2.

Authors:  Baofeng Yang; Huixian Lin; Jiening Xiao; Yanjie Lu; Xiaobin Luo; Baoxin Li; Ying Zhang; Chaoqian Xu; Yunlong Bai; Huizhen Wang; Guohao Chen; Zhiguo Wang
Journal:  Nat Med       Date:  2007-04-01       Impact factor: 53.440

8.  The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis.

Authors:  Markus Landthaler; Abdullah Yalcin; Thomas Tuschl
Journal:  Curr Biol       Date:  2004-12-14       Impact factor: 10.834

9.  Processing of primary microRNAs by the Microprocessor complex.

Authors:  Ahmet M Denli; Bastiaan B J Tops; Ronald H A Plasterk; René F Ketting; Gregory J Hannon
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

10.  MicroRNA profiling of the murine hematopoietic system.

Authors:  Silvia Monticelli; K Mark Ansel; Changchun Xiao; Nicholas D Socci; Anna M Krichevsky; To-Ha Thai; Nikolaus Rajewsky; Debora S Marks; Chris Sander; Klaus Rajewsky; Anjana Rao; Kenneth S Kosik
Journal:  Genome Biol       Date:  2005-08-01       Impact factor: 13.583

View more
  235 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

Review 2.  MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.

Authors:  Ilias Alevizos; Gabor G Illei
Journal:  Autoimmun Rev       Date:  2010-05-10       Impact factor: 9.754

Review 3.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 4.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

5.  Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population.

Authors:  Ying Zeng; Qing-Min Sun; Nan-Nan Liu; Guang-Hui Dong; Jie Chen; Li Yang; Bin Wang
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

6.  Computational functional genomics based analysis of pain-relevant micro-RNAs.

Authors:  Jörn Lötsch; Ellen Niederberger; Alfred Ultsch
Journal:  Hum Genet       Date:  2015-09-18       Impact factor: 4.132

7.  Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Authors:  Amaryllis H Van Craenenbroeck; Kristien J Ledeganck; Katrijn Van Ackeren; Angelika Jürgens; Vicky Y Hoymans; Erik Fransen; Volker Adams; Benedicte Y De Winter; Gert A Verpooten; Christiaan J Vrints; Marie M Couttenye; Emeline M Van Craenenbroeck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 8.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

9.  MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

Authors:  Dan Yang; Wei-Zhi Wang; Xue-Mei Zhang; Hui Yue; Bing Li; Lin Lin; Jin Fu
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

10.  Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.

Authors:  M-C Lu; C-L Yu; H-C Chen; H-C Yu; H-B Huang; N-S Lai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.